Neumora Therapeutics NMRA Q1 2026 Earnings Beat Revenue NA EPS 030 First FCNCN Q1 2026 Beat Revenue NA EPS Exceeds by Significant Political Risk Escalates Lawler Accuses Rand Pauls Son of Antisemitic Tirade EU Negotiators Reach Agreement on Key Clauses of Transatlantic Trade Deal Sam Altman Testifies Elon Musk Sought Total Control of OpenAI Proposed Control for His Children Voya Financial VOYA Flat at 8173 Consolidation Continues 20260515 CSLM KOYNU Stalls at 1025 Breakout or Breakdown 20260515